BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
47 results:

  • 1. [Fully Automatic Glioma Segmentation Algorithm of Magnetic Resonance Imaging Based on 3D-UNet With More Global Contextual Feature Extraction: An Improvement on Insufficient Extraction of Global Features].
    Tian H; Wang Y; Ji Y; Rahman MM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):447-454. PubMed ID: 38645864
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nomograms Based on MRI Radiomics for Differential diagnosis and Predicting BRAFV600E Expression in Pleomorphic Xanthoastrocytoma and Ganglioglioma.
    Kong X; Mao Y; Xi F; Li Y; Luo Y; Ma J
    Acad Radiol; 2024 Mar; 31(3):1069-1081. PubMed ID: 37741731
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
    Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Breastfeeding and risk of childhood brain tumors: a report from the Childhood cancer and Leukemia International Consortium.
    Schraw JM; Petridou ET; Bonaventure A; Dockerty JD; Karalexi M; Ntzani E; Infante-Rivard C; Clavel J; Bracci PM; McKean-Cowdin R; Roman E; Kane E; Erdmann F; Schüz J; Mueller BA; Scheurer ME
    Cancer Causes Control; 2023 Nov; 34(11):1005-1015. PubMed ID: 37421504
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.
    de Godoy LL; Chawla S; Brem S; Wang S; O'Rourke DM; Nasrallah MP; Desai A; Loevner LA; Liau LM; Mohan S
    J Neurooncol; 2023 May; 163(1):173-183. PubMed ID: 37129737
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MR Finding of Extraventricular Neurocytoma.
    Huang S; Liu X; Zhu J; Sun Z; Chen Y; Yu H
    J Coll Physicians Surg Pak; 2022 Nov; 32(11):1478-1482. PubMed ID: 36377019
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study.
    Durmuş ET; Atmaca A; Kefeli M; Çalışkan S; Mete O; Aslan K; Fidan M; Çolak R; Durmuş B
    Growth Horm IGF Res; 2022 Dec; 67():101502. PubMed ID: 36115256
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High Prevalence of Early Endocrine Disorders After Childhood brain Tumors in a Large Cohort.
    González Briceño LG; Kariyawasam D; Samara-Boustani D; Giani E; Beltrand J; Bolle S; Fresneau B; Puget S; Sainte-Rose C; Alapetite C; Pinto G; Piketty ML; Brabant S; Abbou S; Aerts I; Beccaria K; Bourgeois M; Roujeau T; Blauwblomme T; Di Rocco F; Thalassinos C; Pauwels C; Rigaud C; James S; Busiah K; Simon A; Bourdeaut F; Lemelle L; Guerrini-Rousseau L; Orbach D; Touraine P; Doz F; Dufour C; Grill J; Polak M
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2156-e2166. PubMed ID: 34918112
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
    De Herdt C; Philipse E; De Block C
    Eur J Endocrinol; 2021 Jul; 185(2):R65-R74. PubMed ID: 34132199
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of
    Daniel KB; de Oliveira Santos A; de Andrade RA; Trentin MBF; Garmes HM
    J Endocrinol Invest; 2021 Oct; 44(10):2195-2202. PubMed ID: 33569721
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements.
    Neumann NM; Haffner MC; Argani P; Kao CS; Epstein JI
    Am J Surg Pathol; 2021 Feb; 45(2):169-177. PubMed ID: 33002920
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Patterns of palliative care consultation among patients with brain metastasis: an opportunity for radiation oncologists to facilitate earlier referral.
    McDermott DM; Seldomridge A; Maniar A; Mattes MD
    Ann Palliat Med; 2020 Sep; 9(5):3513-3521. PubMed ID: 32921075
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test.
    Han R; Shen L; Zhang J; Xie J; Fang W; Sun Q; Bian L; Zhou Y; Wang S; Ning G; Wang W; Ye L
    Thyroid; 2020 Sep; 30(9):1236-1244. PubMed ID: 32212919
    [No Abstract]    [Full Text] [Related]  

  • 15. First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study.
    Amrane K; Geier M; Corre R; Léna H; Léveiller G; Gadby F; Lamy R; Bizec JL; Goarant E; Robinet G; Gouva S; Quere G; Abgral R; Schick U; Bernier C; Chouaid C; Descourt R
    Cancer Med; 2020 Apr; 9(7):2309-2316. PubMed ID: 32022459
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Imaging Features Suggestive of Multiple Primary Lung Adenocarcinomas.
    Zhang Y; Li G; Li Y; Liu Q; Yu Y; Ma Y; Pan Y; Zhang Y; Hu H; Sun Y; Zhang Y; Xiang J; Chen H
    Ann Surg Oncol; 2020 Jun; 27(6):2061-2070. PubMed ID: 31863415
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.
    Biczok A; Jungk C; Egensperger R; von Deimling A; Suchorska B; Tonn JC; Herold-Mende C; Schichor C
    J Neurooncol; 2019 Dec; 145(3):469-477. PubMed ID: 31713016
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Semiblind Spectral Factorization Approach for Magnetic Resonance Spectroscopy Quantification.
    Ferdowsi S; Abolghasemi V
    IEEE Trans Biomed Eng; 2018 Aug; 65(8):1717-1724. PubMed ID: 29989957
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
    Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
    Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
    J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.